Business Description
ASP Isotopes Inc. is an emerging advanced materials company, currently in its pre-commercial stage. This firm is dedicated to the comprehensive management of isotopes, encompassing their creation, dissemination, promotion, and eventual sale. The company's developmental portfolio includes Molybdenum-100, a non-radioactive isotope designed for medical applications, alongside Carbon-14 and Silicon-28. Furthermore, ASP Isotopes is involved with Uranium-235, a specific uranium isotope considered crucial for the carbon-free energy sector. Established in 2021, the company maintains its headquarters in Boca Raton, Florida.
Business History
Price Overview
Last updated: Jun 27, 2026 8:56am (just now)Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): -2.11
Total Equity: $204.15M
Shares: 83,013,594
Total Debt: $214.43M
Cash: $285.56M
EBITDA: -$157.07M
Total Debt: $214.43M
Cash: $285.56M
Revenue: $23.85M
Shares: 83,013,594
Revenue: $23.85M
Revenue: $23.85M
Revenue: $23.85M
Total Equity: $204.15M
Tax Rate: -0.2%
Equity: $204.15M
Total Debt: $214.43M
Cash: $285.56M
Current Liabilities: $32.70M
Long-Term Debt: $200.79M
Total Debt: $214.43M
Total Equity: $204.15M
Shares: 83,013,594
Shares: 83,013,594
CapEx: -$9.65M
Shares: 83,013,594
Stock Price: $6.17
Net Income: -$175.09M
Industry Benchmarks
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
Income Statement (Annual)
Last updated: Jun 27, 2026 8:56am (just now)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $433,026 | $4.1M | $23.8M |
| Cost of Revenue | $19,376 | $0 | $294,056 | $2.5M | $20.4M |
| Gross Profit | $-19,376 | $0 | $138,970 | $1.6M | $3.4M |
| Operating Expenses | $2.6M | $5.1M | $16.2M | $28.0M | $60.6M |
| Operating Income | -$2.6M | -$5.1M | -$16.0M | -$26.4M | -$57.2M |
| Net Income | -$2.6M | -$4.9M | -$16.3M | -$32.3M | -$175.1M |
| EBITDA | -$2.6M | -$4.9M | -$16.1M | -$31.6M | -$157.1M |
| EPS | $-0.08 | $-0.13 | $-0.49 | $-0.63 | $-2.11 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 27, 2026 8:56am (just now)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $3.0M | $2.4M | $7.9M | $61.9M | $285.6M |
| Total Current Assets | $3.2M | $3.3M | $10.5M | $65.7M | $398.1M |
| Total Assets | $7.1M | $12.5M | $30.2M | $94.3M | $512.9M |
| Current Liabilities | $303,351 | $1.9M | $5.7M | $7.1M | $32.7M |
| Long-Term Debt | $0 | $0 | $0 | $34.9M | $200.8M |
| Total Liabilities | $1.1M | $2.7M | $11.4M | $43.2M | $250.0M |
| Total Equity | $6.0M | $9.8M | $16.3M | $47.9M | $204.2M |
| Retained Earnings | -$2.6M | -$7.6M | -$23.8M | -$56.2M | -$231.3M |
Cash Flow (Annual)
Last updated: Jun 27, 2026 8:56am (just now)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $-577,692 | -$2.9M | -$5.4M | -$16.7M | -$37.8M |
| Capital Expenditure | -$3.0M | -$4.5M | -$2.3M | -$11.4M | -$9.7M |
| Free Cash Flow | -$3.6M | -$7.4M | -$7.7M | -$28.1M | -$47.4M |
| Acquisitions (net) | $0 | $0 | $-121,848 | $0 | $25.4M |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $2.9M | $-564,581 | $5.5M | $54.0M | $223.7M |
Analyst Estimates (Annual)
Last updated: Jun 27, 2026 8:56am (just now)| Metric | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|
| Revenue |
$87.7M $85.3M – $89.8M
|
$257.4M $257.4M – $257.4M
|
$550.0M $535.3M – $563.3M
|
$721.1M $701.9M – $738.6M
|
| EBITDA |
-$17.5M -$18.0M – -$17.1M
|
-$51.5M -$51.5M – -$51.5M
|
-$110.0M -$112.7M – -$107.1M
|
-$144.2M -$147.7M – -$140.4M
|
| Net Income |
-$34.7M -$62.0M – -$7.3M
|
$61.4M $702,057 – $122.2M
|
$215.8M $208.3M – $222.6M
|
$44.0M $42.5M – $45.4M
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jun 27, 2026 8:56am (just now)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | — | — | +857.0% | +475.5% |
| Gross Profit Growth | +100.0% | — | +1,050.6% | +112.9% |
| Operating Income Growth | -95.5% | -214.6% | -64.3% | -117.0% |
| Net Income Growth | -89.6% | -229.3% | -98.5% | -441.5% |
| EBITDA Growth | -88.2% | -231.3% | -95.6% | -397.4% |
Insider Trading (Recent)
All SEC Form 4 codes
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-08 | Ainscow Robert | S-Sale | 8,438.00 | $7.00 | $59,058 |
| 2026-05-28 | Mann Paul Elliot | A-Award | 2,233,555.00 | $0.00 | $0 |
| 2026-06-01 | Mann Paul Elliot | S-Sale | 83,758.00 | $7.88 | $660,013 |
| 2026-06-02 | Mann Paul Elliot | S-Sale | 83,758.00 | $8.29 | $694,354 |
| 2026-06-03 | Mann Paul Elliot | S-Sale | 83,759.00 | $7.76 | $649,970 |
| 2026-05-28 | Ainscow Robert | A-Award | 800,000.00 | $0.00 | $0 |
| 2026-05-28 | Ainscow Donald George | A-Award | 400,000.00 | $0.00 | $0 |
| 2026-05-28 | Kiessling Heather | A-Award | 840,000.00 | $0.00 | $0 |
| 2026-04-16 | Ainscow Robert | S-Sale | 22,500.00 | $5.21 | $117,113 |
| 2026-04-15 | Kiessling Heather | S-Sale | 23,124.00 | $5.48 | $126,673 |
| 2025-12-18 | Moore Duncan | A-Award | 36,548.00 | $0.00 | $0 |
| 2026-04-16 | Moore Duncan | S-Sale | 11,642.00 | $5.21 | $60,597 |
| 2025-11-12 | Moore Duncan | A-Award | 25,469.00 | $0.00 | $0 |
| 2026-03-06 | Ainscow Robert | S-Sale | 25,000.00 | $4.51 | $112,775 |
| 2026-03-06 | Ainscow Robert | S-Sale | 8,438.00 | $5.44 | $45,894 |
| 2026-03-02 | Mann Paul Elliot | S-Sale | 162,153.00 | $5.44 | $881,464 |
| 2025-12-18 | Kiessling Heather | S-Sale | 80,000.00 | $5.80 | $463,840 |
| 2025-12-18 | Wider Todd | A-Award | 36,548.00 | $0.00 | $0 |
| 2025-12-18 | Ryan Robert John Andrew | A-Award | 36,548.00 | $0.00 | $0 |
| 2025-12-18 | Hunter Ralph L. JR | A-Award | 36,548.00 | $0.00 | $0 |
Narrative Economics
market-narrative step).